Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RSPH vs RAGHX overlap: 21% of top holdings shared

Bottom line

How much do RSPH and RAGHX overlap?

21% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 11.0% of RSPH's assets and 23.0% of RAGHX's. They are substantially different portfolios, so owning both adds real diversification.

RSPH holds far more positions (63 vs 24), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

RSPHRAGHX
Weight overlap (top 25)21%
Shared holdings6
Weight in shared holdings11.0%23.0%
Total positions6324
Expense ratio0.4%1.41%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings RSPH and RAGHX have in common

Holding% of RSPH% of RAGHXOverlap
Regeneron Pharmaceuticals, Inc.1.96%2.90%1.96%
Mettler-Toledo International Inc.1.94%3.99%1.94%
Thermo Fisher Scientific Inc.1.84%3.65%1.84%
Amgen Inc.1.77%3.85%1.77%
DexCom, Inc.1.73%3.05%1.73%
AbbVie Inc.1.73%5.52%1.73%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Charles River Laboratories International, Inc. — 1.93%
  5. Veeva Systems Inc. — 1.93%
  6. DaVita Inc. — 1.87%
  7. Moderna, Inc. — 1.85%
  8. Abbott Laboratories — 1.83%
  9. Bristol-Myers Squibb Co. — 1.82%
  10. Universal Health Services, Inc. — 1.80%
  11. Labcorp Holdings Inc. — 1.78%
  12. Quest Diagnostics Inc. — 1.77%
  13. Incyte Corp. — 1.76%
  14. Becton, Dickinson and Co. — 1.73%
  15. Viatris Inc. — 1.72%

Only in RAGHX

  1. Eli Lilly & Company — 14.84%
  2. West Pharmaceutical Services Inc — 5.92%
  3. Vertex Pharmaceuticals Inc — 5.32%
  4. Merck & Company Inc — 5.06%
  5. Unitedhealth Group Inc — 4.65%
  6. Mckesson Corp — 4.57%
  7. Intuitive Surgical Inc — 3.89%
  8. Cooper Companies Inc (the) — 3.81%
  9. Idexx Laboratories Inc — 3.77%
  10. Lumexa Imaging Holdings Inc — 3.60%
  11. Healthequity Inc — 3.47%
  12. Danaher Corp — 3.37%
  13. Align Technology Inc — 2.88%
  14. Steris Plc — 2.32%
  15. U.s. Physical Therapy Inc — 2.30%

Asset mix

Asset typeRSPHRAGHX
Stocks99.9%98.5%
Cash & short-term funds2.3%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryRSPHRAGHX
US98.9%96.2%
IE3.4%2.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do RSPH and RAGHX overlap?
About 21% by weight. 6 securities appear in both funds' top 25 holdings; they make up 11.0% of RSPH's assets and 23.0% of RAGHX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do RSPH and RAGHX have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Inc., Mettler-Toledo International Inc., Thermo Fisher Scientific Inc., Amgen Inc., DexCom, Inc..
Should I own both RSPH and RAGHX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, RSPH or RAGHX?
RSPH is broader, with 63 positions versus 24 for RAGHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.